Advanced Drug Delivery System For Transungual Therapy: Current Strategies And Future Perspectives
Author(s): 1. Utkarsh Gupta, 2. Neeraj Kumar Prajapati, 3. Dr. Anurag Kumar
Authors Affiliations:
¹M. Pharm (Pharmaceutics) Student, Shree Krishna College of Pharmacy, Sitapur, Uttar Pradesh, India, 261125 (Affiliated to Dr. A.P.J. Abdul Kalam Technical University, Lucknow, Uttar Pradesh, India)
²Assistant Professor, Department of Pharmaceutics, Shree Krishna College of Pharmacy, Sitapur, Uttar Pradesh, India, 261125
3Professor, Department of Pharmacology, Shree Krishna College of Pharmacy, Sitapur, Uttar Pradesh, India, 261125
DOIs:10.2017/IJRCS/202606011     |     Paper ID: IJRCS202606011Onychomycosis is a common fungal infection of the nail unit, which is particularly difficult to manage because the dense keratinized structure of the Nail Plate (NP) restricts the penetration of therapeutic agents. Some of the limitations associated with other forms of treatment include systemic toxicity, non-adherence to treatment by the patient as well as inadequate delivery of the drugs to the site of infection. The aim of this narrative review is to provide the general overview of the recent advances in transungual drug delivery systems (TDDS) and to give a particular focus on the strategies which have been developed within the period between 2018-2026. It is a critical analysis of structural and physicochemical obstacles of the nail, traditional treatment hindrances and application of modern delivery modes like microspheres, nanoparticles, vesicular carriers and physical enhancement techniques. Microspheres-in-gel systems have gained considerable attention because they combine sustained drug release with enhanced nail hydration and prolonged residence time, thereby improving drug permeation and retention. The review also identifies important polymers, formulation techniques as well as evaluation techniques used in the research of transungual delivery. Although encouraging in vitro and ex vivo results exist, there still exists a large gap in clinical translation due to a lack of clinical trials and scalability. The future outlook focuses on how smart delivery systems, artificial intelligence, and combination therapies could be used to enhance the therapeutic outcomes.
Utkarsh Gupta, Neeraj Kumar Prajapati, Dr. Anurag Kumar (2026); Advanced Drug Delivery System For Transungual Therapy: Current Strategies And Future Perspectives, International Journal of Research Culture Society, ISSN(O): 2456-6683, Volume – 10, Issue – 6, Available on – https://ijrcs.org/
- de Matos SP, de Oliveira Araujo K, Kreutz T, da Veiga Júnior VF, Teixeira HF, Koester LS. Nanocarriers in Ungual Drug Delivery. Pharmaceutics. 2025;17(8):1060. doi:10.3390/pharmaceutics17081060
- Abd-Elsalam WH, Abouelatta SM. Contemporary techniques and potential transungual drug delivery nanosystems for the treatment of onychomycosis. AAPS PharmSciTech. 2023;24(6):150. doi:10.1208/s12249-023-02603-x
- Hussain NV, Premaletha K. Recent advancement in transungual therapies: a comprehensive approach to onychomycosis. World Journal of Pharmaceutical Research. 2024;16(4). doi:10.20959/wjpr202416-33517
- Bedanta B, Nikita D, Dhunusmita B, Arka K, Nasima A. Understanding the drug delivery through nails: a comprehensive review. Journal of Drug Delivery & Therapeutics. 2021;11(4). doi:10.22270/jddt.v11i4.4941
- Thatai P, Khan AB. Management of nail psoriasis by topical drug delivery: a pharmaceutical perspective. International Journal of Dermatology. 2020;59(8):915-25. doi:10.1111/ijd.14840
- Witika BA, Mweetwa LL, Tshiamo KO, Edler K, Matafwali SK, Ntemi PV, Chikukwa MT, Makoni PA. Vesicular drug delivery for the treatment of topical disorders: current and future perspectives. Journal of Pharmacy and Pharmacology. 2021;73(11):1427-41. doi:10.1093/jpp/rgab082
- Lal B, Shukla MK, Srivastava H, Pal PK, Khan W. Contemporary Strategies for Treating Nail Disorders: A Study of Transungual Drug Delivery Systems. Journal of Pharmaceutical Sciences. 2025;1(11):940-946. doi:10.5281/zenodo.17628502
- Sousa F, Ferreira D, Reis S, Costa P. Current insights on antifungal therapy: Novel nanotechnology approaches for drug delivery systems and new drugs from natural sources. 2020;13(9):248. doi:10.3390/ph13090248
- Fernández-Campos F, Navarro F, Corrales A, Picas J, Pena E, González J, Otero-Espinar FJ. Transungual delivery, anti-inflammatory activity, and in vivo assessment of a cyclodextrin polypseudorotaxanes nail lacquer. 2020;12(8):730. doi:10.3390/pharmaceutics12080730
- Farheen F, Yadav HK, Raizaday A, Dhakad K. Updated perspectives on the diagnosis, Management and novel drug delivery strategies for the treatment of onychomycosis. Journal of Pharmceutical Negative Results. 2022;13(8):3669-3690. doi:10.47750/Pnr.2022.13.S08.455
- Sharma S, Chopra H, Pahwa R, Emran TB, Singh I. Novel transungual drug delivery system for treating onychomycosis. International Journal of Surgery. 2023;109(7):2145-7. doi:1097/JS9.0000000000000041
- Aggarwal R, Targhotra M, Sahoo PK, Chauhan MK. Efinaconazole nail lacquer for the transungual drug delivery: Formulation, optimization, characterization and in vitro evaluation. Journal of Drug Delivery Science and Technology. 2020;60:101998. doi:10.1016/j.jddst.2020.101998
- Lee SH, Yang CS. Fingernail analysis management system using microscopy sensor and blockchain technology. International Journal of Distributed Sensor Networks. 2018;14(3):1550147718767044. doi:10.1177/1550147718767044
- Leu JS, Teoh JJ, Ling AL, Chong J, Loo YS, Mat Azmi ID, Zahid NI, Bose RJ, Madheswaran T. Recent advances in the development of liquid crystalline nanoparticles as drug delivery systems. 2023;15(5):1421. doi:10.3390/pharmaceutics15051421
- Chavan GS, Belgamwar A, Patil KD, Agrawal YO. Mechanistic understanding of onychomycosis progression and current advancement in the transungual drug delivery system. Critical Reviews in Therapeutic Drug Carrier Systems. 2025;42. doi:10.1615/CritRevTherDrugCarrierSyst.2024053869
- Gulhane CA, Motule AS, Atram SC, Mankar LM, Deshmukh DA, Bakal RL. An overview on nail drug delivery system: a promising application for various diseases. European Journal of Biomedical and Pharmaceutical Sciences. 2021;8(2):104–110. doi:10.17605/OSF.IO/WHNJR
- Konisky H, Klinger R, Coe L, Jaller JA, Cohen JL, Kobets K. A focused review on laser-and energy-assisted drug delivery for nail disorders. Lasers in medical science. 2024;39(1):39. doi:10.1007/s10103-024-03992-6
- Kandav G, Verma A. Transungual Drug Delivery: A Holistic Review of Nail Anatomy, Penetration Enhancement Techniques, Formulation Strategies, and Experimental Models. Journal of Drug Delivery Science and Technology. 2025:107428. doi:10.1016/j.jddst.2025.107428
- Kaur S, Kumar M, Bhatia A, Chopra S. A recent review on transungual drug delivery system. Journal of Dispersion Science and Technology. 2025;46(10):1510-29. doi:10.1080/01932691.2024.2334012
- Lee BC, Pangeni R, Na J, Koo KT, Park JW. Preparation and in vivo evaluation of a highly skin-and nail-permeable efinaconazole topical formulation for enhanced treatment of onychomycosis. Drug Delivery. 2019;26(1):1167-77. doi:10.1080/10717544.2019.1687612
- Bhairy S, Momin A, Pednekar M, Madan D, Shaikh A, Bankar R, Pitchika S. A note on the Current status of the trans-ungual delivery of poorly soluble drugs at a glance: formulation perspective. Asian Journal of Research in Infectious. 2023;12:1-21. doi:10.9734/AJRID/2023/v12i3244
- Cutrín-Gómez E, Anguiano-Igea S, Delgado-Charro MB, Gómez-Amoza JL, Otero-Espinar FJ. Effect of penetration enhancers on drug nail permeability from cyclodextrin/poloxamer-soluble polypseudorotaxane-based nail lacquers. Pharmaceutics. 2018;10(4):273. doi:10.3390/pharmaceutics10040273
- Kreutz T, de Matos SP, Koester LS. Recent patents on permeation enhancers for drug delivery through nails. Recent patents on drug delivery & formulation. 2019;13(3):203-218. doi:10.2174/1872211313666191030155837
- Monti D, Mazzantini D, Tampucci S, Vecchione A, Celandroni F, Burgalassi S, Ghelardi E. Ciclopirox and efinaconazole transungual permeation, antifungal activity, and proficiency to induce resistance in Trichophyton rubrum. Antimicrobial Agents and Chemotherapy. 2019;63(10):e00442-19. doi:10.1128/aac.00442-19
- Prajapati SK, Jain A, Bajpai M. Lipid-based nanoformulations in onychomycosis therapy: addressing challenges of current therapies and advancing treatment. RSC advances. 2025;15(10):7799-7825. doi: 1039/D5RA00387C
- Davies-Strickleton H, Cook J, Hannam S, Bennett R, Gibbs A, Edwards D, Ridden C, Ridden J, Cook D. Assessment of the nail penetration of antifungal agents, with different physico-chemical properties. PLoS One. 2020;15(2):e0229414. doi:10.1371/journal.pone.0229414
- Hay R. Therapy of skin, hair and nail fungal infections. Journal of Fungi. 2018;4(3):99. doi:10.3390/jof4030099
- Prashanth S, Umasankar K, Venugopal K. A strategic approach on ungual drug delivery system. Archives of Medicine and Health Sciences. 2024;12(2):1–7. doi:10.4103/amhs.amhs_383_24
- Gupta I, Adin SN, Rashid MA, Alhamhoom Y, Aqil M, Mujeeb M. Linalool-incorporated synergistically engineered modified liposomal nanocarriers for enhanced transungual delivery of terbinafine against onychomycosis. 2023;16(12):4424. doi:10.3390/ma16124424
- Ullah KH, Raza F, Munawar SM, Sohail M, Zafar H, Zafar MI, Ur-Rehman T. Poloxamer 407 based gel formulations for transungual delivery of hydrophobic drugs: Selection and optimization of potential additives. Polymers. 2021;13(19):3376. doi:10.3390/polym13193376
- Šveikauskaitė I, Pockevičius A, Briedis V. Potential of chemical and physical enhancers for transungual delivery of amorolfine hydrochloride. Materials. 2019;12(7):1028. doi:10.3390/ma12071028
- Nair AB, Al-Dhubiab BE, Shah J, Gorain B, Jacob S, Attimarad M, Sreeharsha N, Venugopala KN, Morsy MA. Constant voltage iontophoresis technique to deliver terbinafine via Transungual delivery system: formulation optimization using box-Behnken design and In vitro evaluation. 2021;13:1692. doi:10.3390/pharmaceutics13101692
- Nikhath M, Sanjana S. Formulation and evaluation of nail drug delivery system of anti fungal drug. Asian Journal of Pharmaceutical Research and Development. 2022;10(6):44-52. doi:10.22270/ajprd.v10i6.1189
- Muthukumar M, Arunpandiyan J, Rajeev T, Thaila R, Jayalakshmi B, Senthilraja M. New insights of transungual delivery of phytoconstituents loaded nail lacquer for therapy of nail diseases. Indo American Journal of pharmaceutical Research. 2023;13(6):934-943. doi:10.5281/zenodo.8081182.
- García‐Oreja S, Álvaro‐Afonso FJ, Navarro‐Pérez D, León‐Herce D, Tardáguila‐García A, Lázaro‐Martínez JL. Diode Laser and Red‐Laser Photodynamic Therapy Versus Ciclopirox 8% HPCH Nail Lacquer for the Treatment of Onychomycosis: A Randomised Controlled Trial. Mycoses. 2025;68(10):e70121. doi:10.1111/myc.70121
- Gregoriou S, Kyriazopoulou M, Tsiogka A, Rigopoulos D. Novel and investigational treatments for onychomycosis. Journal of Fungi. 2022;8(10):1079. doi:10.3390/jof8101079
- Khattab A, Shalaby S. Optimized ciclopirox-based eudragit RLPO nail lacquer: Effect of endopeptidase enzyme as permeation enhancer on transungual drug delivery and efficiency against onychomycosis. AAPS PharmSciTech. 2018;19(3):1048-60. doi:10.1208/s12249-017-0917-8
- Puri V, Savla R, Chen K, Robinson K, Virani A, Michniak-Kohn B. Antifungal nail lacquer for enhanced transungual delivery of econazole nitrate. Pharmaceutics. 2022;14(10):2204. doi:10.3390/pharmaceutics14102204
- Ullah KH, Rasheed F, Naz I, Ul Haq N, Fatima H, Kanwal N, Ur-Rehman T. Chitosan nanoparticles loaded poloxamer 407 gel for transungual delivery of terbinafine HCl. Pharmaceutics. 2022;14(11):2353. doi:10.3390/pharmaceutics14112353
- Almuqbil RM, Sreeharsha N, Nair AB. Formulation-by-design of efinaconazole spanlastic nanovesicles for transungual delivery using statistical risk management and multivariate analytical techniques. Pharmaceutics. 2022;14(7):1419. doi:10.3390/pharmaceutics14071419
- Vora LK, Gholap AD, Jetha K, Thakur RR, Solanki HK, Chavda VP. Artificial intelligence in pharmaceutical technology and drug delivery design. Pharmaceutics. 2023;15(7):1916. doi:10.3390/pharmaceutics15071916
- Wang S, Di J, Wang D, Dai X, Hua Y, Gao X, Zheng A, Gao J. State-of-the-art review of artificial neural networks to predict, characterize and optimize pharmaceutical formulation. 2022;14(1):183. doi:10.3390/pharmaceutics14010183
- Hornick T, Mao C, Koynov A, Yawman P, Thool P, Salish K, Giles M, Nagapudi K, Zhang S. In silico formulation optimization and particle engineering of pharmaceutical products using a generative artificial intelligence structure synthesis method. Nature Communications. 2024;15(1):9622. doi:10.1038/s41467-024-54011-9

